At a glance
ClinicalIndex Comparison RecordN/AUnknown· 200 target
Drug / intervention
Biopsy/surgical tissue and peripheral bloodprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Research on Neuroendocrine Neoplasm in a Single Center Based on Multi-omics Integrated Analysis
In Brief
An observational study evaluating Biopsy/surgical tissue and peripheral blood for Neuroendocrine Neoplasm. Targeting 200 participants across 1 site.
Detailed Summary
This project intends to analyze the molecular biological characteristics of NEN based on multi-omics, develop an exclusive NEN multi-omics big data platform, and carry out molecular subtypes and potential targets prediction, so as to improve the therapeutic effect of neuroendocrine tumors.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsNeuroendocrine Neoplasm
CountriesChina
Collaborators--
Timeline
N/AUnknownOverdue
20222023202420252026
First PostedJun 2021
Enrollment StartJul 2021
Primary CompletionMar 2022
Study CompletionDec 2022
TodayJul 2026
First PostedJun 18, 2021
Enrollment StartJul 1, 2021
Primary CompletionMar 1, 2022
Study CompletionDec 1, 2022
TodayJul 1, 2026
Enrollment to primary: 8 monthsPosted 5.0 years ago
Interventions
Biopsy/surgical tissue and peripheral bloodprocedure
Retrieve specimens stored in the tissue bank, the main types of samples are RNAlater specimens, liquid nitrogen frozen specimens and peripheral blood specimens